United Therapeutics Corp (UTHR)
355.93
+5.86
(+1.67%)
USD |
NASDAQ |
Oct 04, 16:00
358.98
+3.05
(+0.86%)
After-Hours: 20:00
United Therapeutics Shareholders Equity (Annual): 5.985B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 5.985B |
December 31, 2022 | 4.797B |
December 31, 2021 | 3.959B |
December 31, 2020 | 3.395B |
December 31, 2019 | 2.780B |
December 31, 2018 | 2.808B |
December 31, 2017 | 2.121B |
December 31, 2016 | 1.862B |
December 31, 2015 | 1.600B |
December 31, 2014 | 1.266B |
December 31, 2013 | 1.304B |
December 31, 2012 | 1.095B |
December 31, 2011 | 959.37M |
Date | Value |
---|---|
December 31, 2010 | 883.89M |
December 31, 2009 | 653.01M |
December 31, 2008 | 555.33M |
December 31, 2007 | 295.79M |
December 31, 2006 | 204.61M |
December 31, 2005 | 275.10M |
December 31, 2004 | 191.64M |
December 31, 2003 | 167.76M |
December 31, 2002 | 171.66M |
December 31, 2001 | 196.40M |
December 31, 2000 | 234.74M |
December 31, 1999 | 53.60M |
December 31, 1998 | 16.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
2.780B
Minimum
2019
5.985B
Maximum
2023
4.183B
Average
3.959B
Median
2021
Shareholders Equity (Annual) Benchmarks
Liquidia Corp | 47.29M |
Catalent Inc | 3.604B |
Amgen Inc | 6.232B |
Merck & Co Inc | 37.58B |
AbbVie Inc | 10.36B |